by Mike Masnick
Wed, Aug 12th 2009 5:08am
Earlier this year, it was revealed that publishing giant Elsevier had allowed pharma king Merck to create a fake peer reviewed journal that hyped up certain Merck products, such that doctors would think that there was some serious science behind them. It later came out that Elsevier actually had a whole division which specialized in publishing such fake journals, made to appear real, and given the Elsevier stamp of approval (which hopefully is now becoming worthless). But, it appears things keep getting worse. Coral Hess notes yet another scandal, once again involving Elsevier's (now) fake stamp of approval. This time, it involved people hired by certain pharma companies ghostwriting scientific "review" articles that were supposed to give an overview of all the research on certain treatments, but... "emphasized the benefits and de-emphasized the risks" of those treatments. And people wonder why we're so skeptical about allowing pharma companies to dictate both our healthcare plans and our patent laws...
If you liked this post, you may also be interested in...
- Cable Lobbyists Stop Using The Word Cable In Hopes You'll Think Industry Has Evolved
- Stupid Patent Of The Month: Elsevier Patents Online Peer Review
- Just As Open Competitor To Elsevier's SSRN Launches, SSRN Accused Of Copyright Crackdown
- Daily Deal: Pay What You Want: The Marketing Copywriter Bundle
- As Expected, Verizon's Attempt To Woo Millennials Is Falling Flat On Its Face